OCGN OCUGEN
Health Care · Russell 2000
Next earnings: not announced yet
What 9 analyst firms say about OCUGEN: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
8 rated views · 9 analyst/firm records · 9 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Price below 5 USD
- Russell 2000 · Safest consensus · 6MNot scored · Price below 5 USD
Recent analyst activity · last 90 days
Our tracked history has 2 reports on OCGN from 2 analyst firms in the last 90 days (9 firms in the past year).
Comparing each firm's latest target with its previous one: 1 lowered it.
No firm's latest available rating differs from its previous one.
Latest observed target change: HC Wainwright lowered its target from $10.00 (set 7 Aug 2026) to $9.50 on 10 Sep 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Canaccord Genuity | Whitney Ijem | Buy | 27 May 2026 | 11.00 USD |
| Chardan Capital Markets | Daniil Gataulin | Buy | 25 Mar 2026 | 7.00 USD |
| H.C. Wainwright | Swayampakula Ramakanth | Buy | 7 Aug 2026 | 10.00 USD |
| Lucid Capital Markets | Elemer Piros | Buy | 13 Jul 2026 | 22.00 USD |
| Maxim Group | Michael Okunewitch | Buy | 7 Mar 2026 | 8.00 USD |
| Noble Capital Markets | Robert Leboyer | Buy | 30 Jul 2026 | 12.00 USD |
| Oppenheimer | Leland Gershell | Buy | 11 Mar 2026 | 10.00 USD |
| Weiss Ratings | Unnamed analyst | — | 11 Aug 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | 1.25 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 07:04 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.